Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening

Influenza A virus (IAV) infections cause major morbidity and mortality, generating an urgent need for novel antiviral therapeutics. We recently established a dual myxovirus high-throughput screening protocol that combines a fully replication-competent IAV-WSN strain and a respiratory syncytial virus...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Virol
Hauptverfasser: Weisshaar, Marco, Cox, Robert, Morehouse, Zachary, Kumar Kyasa, Shiva, Yan, Dan, Oberacker, Phil, Mao, Shuli, Golden, Jennifer E., Lowen, Anice C., Natchus, Michael G., Plemper, Richard K.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2016
Schlagworte:
Vaccines and Antiviral Agents
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984618/
https://ncbi.nlm.nih.gov/pubmed/27252534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00898-16
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge